Just Earth News | @justearthnews | 04 May 2021, 01:20 am Print
Pfizer-BioNTech Image: Pixabay
Washinton/Sputnik: The US Food and Drug Administration (FDA) is preparing to approve the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15, The New York Times reported, citing federal officials.
The authorization is expected to come early next week, the report said on Monday.
Pfizer announced several weeks ago that none of the adolescents who have received the vaccine during trials have contracted a symptomatic case of COVID-19.
However, plans to vaccinate teens and children, who rarely contract serious cases of the illness, have sparked debate, the report added, as many question whether excess US vaccines could be put to better use on adults in other countries.
- Hot tea, hot coffee and cancer: Oxford study raises a new warning
- Taking Ozempic or Wegovy? Study finds possible link to hair loss in men
- Bhutan makes history: WHO declares country free of dog-transmitted Rabies
- Sugar-free but not risk-free? Study raises alarm over popular sweetener
- Type 2 diabetes affects men and women differently: New study unveils a shocking health divide
